Accelerating Diabetes Prevention
98 million
people with prediabetes in the US
$43 billion
collective annual burden
Current glucose monitors are invasive, painful, designed for people with diabetes, produce medical waste and they are not covered by insurance for people with prediabetes
>$1,000/year
Our mission is to reverse prediabetes and reduce the risk of diabetes. Our non-invasive AI-enabled wearable technology addresses the unmet needs of
Zero physical pain
Zero medical waste
Accessible price point
We leverage GenAI to support realistic and lasting behavioral change
Make healthful eating low burden
Improve individual decision making
Adapt suggestions with user’s life
Supported by
